Generalised anxiety disorder: Difference between revisions
No edit summary |
Ollama: improve existing draft article |
||
| Line 1: | Line 1: | ||
[[Generalised anxiety disorder]] (GAD) is a common mental health condition characterised by excessive, persistent, and uncontrollable worry about everyday events and activities. Unlike normal anxiety, which is typically situational and temporary, GAD involves chronic anxiety that significantly interferes with daily functioning. Symptoms may include restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbances. The disorder is often comorbid with other mental health conditions, such as depression, and can lead to significant impairment in personal, social, and occupational domains. |
|||
| ⚫ | |||
{{H2|Definition and Diagnostic Criteria}} |
|||
According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), GAD is diagnosed when an individual experiences excessive anxiety and worry about multiple events or activities for at least six months. The worry must be difficult to control, accompanied by at least three of the following symptoms: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbances. These symptoms must cause clinically significant distress or impairment and cannot be better explained by another medical condition or mental disorder. |
|||
{{H2|Prevalence and Risk Factors}} |
|||
GAD affects approximately 3–5% of the global population at any given time, with women being twice as likely as men to be diagnosed. Risk factors include a family history of anxiety disorders, childhood adversity, personality traits such as neuroticism, and chronic stressors. The disorder often begins in childhood or adolescence, though it can develop at any age. |
|||
{{H2|Causes and Pathophysiology}} |
|||
The exact causes of GAD are not fully understood, but research suggests a combination of genetic, neurobiological, and environmental factors. Neuroimaging studies have identified abnormalities in brain regions involved in emotional regulation, such as the prefrontal cortex and amygdala. Dysregulation of neurotransmitters like serotonin and gamma-aminobutyric acid (GABA) is also implicated. Additionally, maladaptive cognitive patterns, such as catastrophizing and overestimating threats, contribute to the persistence of anxiety. |
|||
{{H2|Treatment and Management}} |
|||
Treatment for GAD typically involves a combination of psychotherapy and pharmacotherapy. Cognitive behavioral therapy (CBT) is the most evidence-based psychological intervention, focusing on identifying and modifying unhelpful thought patterns and behaviors. Medications such as selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines may be prescribed, though the latter are usually limited to short-term use due to the risk of dependence. Lifestyle modifications, including regular physical activity, mindfulness practices, and stress management techniques, are also recommended as adjunctive therapies. |
|||
{{H2|Prognosis and Impact on Quality of Life}} |
|||
With appropriate treatment, many individuals with GAD experience significant improvement in symptoms and quality of life. However, the disorder is often chronic, and relapse is common without ongoing management. Untreated GAD can lead to severe functional impairment, increased risk of substance use disorders, and higher healthcare utilization. Early intervention and a multidisciplinary approach are critical to optimizing long-term outcomes. |
|||
{{H2|Research and Current Studies}} |
|||
Recent research has explored the role of digital health interventions in managing GAD. A study published on [https://www.psypost.org/2023/11/internet-use-predicts-heightened-anxiety-symptoms-in-adolescent-girls-but-not-boys-214501 psypost.org] highlights the potential link between excessive internet use and heightened anxiety symptoms in adolescent girls, though the relationship remains complex and context-dependent. Ongoing studies continue to investigate the efficacy of teletherapy, mobile applications, and wearable devices in supporting anxiety management. |
|||
{{H2|References}} |
|||
| ⚫ | |||
- American Psychiatric Association. (2013). *Diagnostic and Statistical Manual of Mental Disorders* (5th ed.). |
|||
- National Institute of Mental Health. (n.d.). *Generalized Anxiety Disorder*. |
|||
{{Anxiety}} |
{{Anxiety}} |
||
{{Draft}} |
|||
{{Ollama}} |
|||
{{Pending Human Review}} |
|||
Latest revision as of 22:03, 31 October 2026
Generalised anxiety disorder (GAD) is a common mental health condition characterised by excessive, persistent, and uncontrollable worry about everyday events and activities. Unlike normal anxiety, which is typically situational and temporary, GAD involves chronic anxiety that significantly interferes with daily functioning. Symptoms may include restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbances. The disorder is often comorbid with other mental health conditions, such as depression, and can lead to significant impairment in personal, social, and occupational domains.
Definition and Diagnostic Criteria
According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), GAD is diagnosed when an individual experiences excessive anxiety and worry about multiple events or activities for at least six months. The worry must be difficult to control, accompanied by at least three of the following symptoms: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbances. These symptoms must cause clinically significant distress or impairment and cannot be better explained by another medical condition or mental disorder.
Prevalence and Risk Factors
GAD affects approximately 3–5% of the global population at any given time, with women being twice as likely as men to be diagnosed. Risk factors include a family history of anxiety disorders, childhood adversity, personality traits such as neuroticism, and chronic stressors. The disorder often begins in childhood or adolescence, though it can develop at any age.
Causes and Pathophysiology
The exact causes of GAD are not fully understood, but research suggests a combination of genetic, neurobiological, and environmental factors. Neuroimaging studies have identified abnormalities in brain regions involved in emotional regulation, such as the prefrontal cortex and amygdala. Dysregulation of neurotransmitters like serotonin and gamma-aminobutyric acid (GABA) is also implicated. Additionally, maladaptive cognitive patterns, such as catastrophizing and overestimating threats, contribute to the persistence of anxiety.
Treatment and Management
Treatment for GAD typically involves a combination of psychotherapy and pharmacotherapy. Cognitive behavioral therapy (CBT) is the most evidence-based psychological intervention, focusing on identifying and modifying unhelpful thought patterns and behaviors. Medications such as selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines may be prescribed, though the latter are usually limited to short-term use due to the risk of dependence. Lifestyle modifications, including regular physical activity, mindfulness practices, and stress management techniques, are also recommended as adjunctive therapies.
Prognosis and Impact on Quality of Life
With appropriate treatment, many individuals with GAD experience significant improvement in symptoms and quality of life. However, the disorder is often chronic, and relapse is common without ongoing management. Untreated GAD can lead to severe functional impairment, increased risk of substance use disorders, and higher healthcare utilization. Early intervention and a multidisciplinary approach are critical to optimizing long-term outcomes.
Research and Current Studies
Recent research has explored the role of digital health interventions in managing GAD. A study published on psypost.org highlights the potential link between excessive internet use and heightened anxiety symptoms in adolescent girls, though the relationship remains complex and context-dependent. Ongoing studies continue to investigate the efficacy of teletherapy, mobile applications, and wearable devices in supporting anxiety management.
References
- psypost.org - American Psychiatric Association. (2013). *Diagnostic and Statistical Manual of Mental Disorders* (5th ed.). - National Institute of Mental Health. (n.d.). *Generalized Anxiety Disorder*.
This page contains information generated by Ollama. The information was reviewed, and may have been altered, by a human editor before being added to the Featured category. As of July 2026 information generated by AI is not subject to copyright and is thus in the public domain. This page is pending human review.